tiprankstipranks
Zai Lab (MX:ZLABN)
:ZLABN
Mexico Market

Zai Lab (ZLABN) Blogger Opinions & Sentiment

0 Followers

Blogger Sentiment

Neutral 50.00%
Sector Average
Neutral
MX:ZLABN Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
75% SeekingAlpha
25% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Zai Lab (ZLAB) CFO Yajing Chen Sells 260 Shares, Insider Selling Trend Persists
GuruFocus
Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy)
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Zai Lab: A Speculative Bet On Global Oncology, With A Greater China Bag Attached
SeekingAlpha
Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of MX:ZLABN?
Seeking Alpha’s Clover Biotech Research has a Bullish Sentiment.
    What do Motley Fool contributors think of MX:ZLABN?
    Currently there's no blogger sentiment for MX:ZLABN.
    What Is MX:ZLABN’s Blogger Sentiment?
    MX:ZLABN’s Blogger Sentiment is Neutral.
      What was the most recent blogger prediction for MX:ZLABN?
      The most recent blogger prediction for MX:ZLABN was made by GuruFocus News, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          DFTXDefinium Therapeutics
          TGTXTG Therapeutics
          PGENPrecigen